These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23225170)

  • 1. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
    Jia C; Cai Y; Ma Y; Fu D
    Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer susceptibility variants alter risks in familial disease.
    Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
    J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
    Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
    J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
    Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
    Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
    Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
    Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Leaw SJ; Wang BY; Wang JL; Cao ZG; Gao JL; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(2):419-24. PubMed ID: 20300826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
    Chen XH; Li XQ; Chen Y; Feng YM
    Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer genome-wide association studies: there is strength in numbers.
    Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
    Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
    Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
    Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
    Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
    Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
    Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
    Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
    Gates MA; Tworoger SS; Terry KL; De Vivo I; Hunter DJ; Hankinson SE; Cramer DW
    Int J Cancer; 2009 Feb; 124(3):729-33. PubMed ID: 18973230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
    Leyton Y; Gonzalez-Hormazabal P; Blanco R; Bravo T; Fernandez-Ramires R; Morales S; Landeros N; Reyes JM; Peralta O; Tapia JC; Gomez F; Waugh E; Ibañez G; Pakomio J; Grau G; Jara L
    BMC Cancer; 2015 Jan; 15():30. PubMed ID: 25636233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Spurdle AB; Sinilnikova OM; Healey S; Pooley KA; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Hofmann W; Sutter C; Niederacher D; Deissler H; Caldes T; Kämpjärvi K; Nevanlinna H; Simard J; Beesley J; Chen X; ; Neuhausen SL; Rebbeck TR; Wagner T; Lynch HT; Isaacs C; Weitzel J; Ganz PA; Daly MB; Tomlinson G; Olopade OI; Blum JL; Couch FJ; Peterlongo P; Manoukian S; Barile M; Radice P; Szabo CI; Pereira LH; Greene MH; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; ; Gerdes AM; Caligo MA; Laitman Y; Kaufman B; Milgrom R; Friedman E; ; Domchek SM; Nathanson KL; Osorio A; Llort G; Milne RL; Benítez J; Hamann U; Hogervorst FB; Manders P; Ligtenberg MJ; van den Ouweland AM; ; Peock S; Cook M; Platte R; Evans DG; Eeles R; Pichert G; Chu C; Eccles D; Davidson R; Douglas F; ; Godwin AK; Barjhoux L; Mazoyer S; Sobol H; Bourdon V; Eisinger F; Chompret A; Capoulade C; Bressac-de Paillerets B; Lenoir GM; Gauthier-Villars M; Houdayer C; Stoppa-Lyonnet D; ; Chenevix-Trench G; Easton DF;
    Am J Hum Genet; 2008 Apr; 82(4):937-48. PubMed ID: 18355772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.